Literature DB >> 34408449

Methicillin and Vancomycin Resistant Staphylococcus aureus and Associated Factors from Surgical Ward Inpatients at Debre Markos Referral Hospital, Northwest Ethiopia.

Samrawit Tefera1,2, Tewachew Awoke1, Daniel Mekonnen1,3.   

Abstract

INTRODUCTION: Staphylococcus aureus is a well-known superbug and leading causes of wound infections. The clinical epidemiology of methicillin resistant S. aureus (MRSA) and vancomycin resistant S. aureus (VRSA) is not well documented in Ethiopia. The aim of this study was to determine the proportion of MRSA, VRSA and associated factors from surgical inpatients in Debre Markos Referral Hospital (DMRH), Northwest Ethiopia.
METHODS: A facility-based cross-sectional study was conducted from February to April 2020 at DMRH. A structured questionnaire was used to gather demographic and clinical data. Wound swab was collected from inpatients and then inoculated on blood agar and mannitol salt agar. The presence of MRSA and VRSA was determined using the cefoxitin (30 μg) antibiotic disk diffusion and vancomycin E-test methods, respectively. The data were analyzed using SPSS 20. Data were analyzed using bivariate and multivariate logistic regression analysis. A P-value <0.05 was considered statistically significant.
RESULTS: A total of 242 wound cases were enrolled and the majority of them were males 172 (71.1%). Among the total enrolled cases, S. aureus was identified from 71 (29.3%) of the admitted patients. The proportion of MRSA was 32 (13.22%) and that of VRSA was 4.1%. The proportion of vancomycin intermediate S. aureus (VISA) was gauged at 4.5%. Hospital stay over 72 hrs, wound depth, current antibiotic use, and previous history of wound infection showed statistically significant association with MRSA. On the contrary, VRSA did not showed any significant association against the analyzed variables.
CONCLUSION: High proportions of S. aureus isolates became MRSA; resistant to all β-lactam antimicrobial agents excluding newer cephalosporin. In addition, the proportion of VRSA/VISA was also high. Multiple variables demonstrated significant associations with MRSA. Hence, intervention measures for MRSA risk groups must be in place. Furthermore, hospital infection control and an antibiotic stewardship program should be strengthened.
© 2021 Tefera et al.

Entities:  

Keywords:  Debre Markos Referral Hospital; Ethiopia; MRSA; Nosocomial infection; VRSA; surgical inpatients

Year:  2021        PMID: 34408449      PMCID: PMC8364347          DOI: 10.2147/IDR.S324042

Source DB:  PubMed          Journal:  Infect Drug Resist        ISSN: 1178-6973            Impact factor:   4.003


  26 in total

Review 1.  Community-associated meticillin-resistant Staphylococcus aureus.

Authors:  Frank R DeLeo; Michael Otto; Barry N Kreiswirth; Henry F Chambers
Journal:  Lancet       Date:  2010-03-05       Impact factor: 79.321

2.  Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.

Authors:  Peter G Kelley; Wei Gao; Peter B Ward; Benjamin P Howden
Journal:  J Antimicrob Chemother       Date:  2011-03-02       Impact factor: 5.790

3.  Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals.

Authors:  Erica M C D'Agata; Glenn F Webb; Mary Ann Horn; Robert C Moellering; Shigui Ruan
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

4.  Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad.

Authors:  Venubabu Thati; Channappa T Shivannavar; Subhaschandra M Gaddad
Journal:  Indian J Med Res       Date:  2011-11       Impact factor: 2.375

5.  Evaluation of Antimicrobial Resistance in Staphylococcus aureus Isolates by Years.

Authors:  Cennet Rağbetli; Mehmet Parlak; Yasemin Bayram; Huseyin Guducuoglu; Nesrin Ceylan
Journal:  Interdiscip Perspect Infect Dis       Date:  2016-05-09

6.  Methicillin resistant Staphylococcus aureus in Ethiopia: a meta-analysis.

Authors:  Setegn Eshetie; Fentahun Tarekegn; Feleke Moges; Anteneh Amsalu; Wubet Birhan; Kahsay Huruy
Journal:  BMC Infect Dis       Date:  2016-11-21       Impact factor: 3.090

7.  Prevalence of vancomycin resistant Staphylococcus aureus (VRSA) in methicillin resistant S. aureus (MRSA) strains isolated from burn wound infections.

Authors:  Rashedul Hasan; Mrityunjoy Acharjee; Rashed Noor
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2016-04-23

8.  The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis.

Authors:  Helen J Stacey; Caitlin S Clements; Susan C Welburn; Joshua D Jones
Journal:  Acta Diabetol       Date:  2019-04-06       Impact factor: 4.280

9.  Methicillin-Resistant Staphylococcus aureus (MRSA): Prevalence and Antimicrobial Sensitivity Pattern among Patients-A Multicenter Study in Asmara, Eritrea.

Authors:  Eyob Yohaness Garoy; Yacob Berhane Gebreab; Oliver Okoth Achila; Daniel Goitom Tekeste; Robel Kesete; Robel Ghirmay; Ruta Kiflay; Thomas Tesfu
Journal:  Can J Infect Dis Med Microbiol       Date:  2019-02-06       Impact factor: 2.471

10.  Prevalence and antibiotic susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) among primary school children and prisoners in Jimma Town, Southwest Ethiopia.

Authors:  Tekalign Kejela; Ketema Bacha
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-06-04       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.